Your browser doesn't support javascript.
loading
FER regulates endosomal recycling and is a predictor for adjuvant taxane benefit in breast cancer.
Tavares, Sandra; Liv, Nalan; Pasolli, Milena; Opdam, Mark; Rätze, Max A K; Saornil, Manuel; Sluimer, Lilian M; Hengeveld, Rutger C C; van Es, Robert; van Werkhoven, Erik; Vos, Harmjan; Rehmann, Holger; Burgering, Boudewijn M T; Oosterkamp, Hendrika M; Lens, Susanne M A; Klumperman, Judith; Linn, Sabine C; Derksen, Patrick W B.
Affiliation
  • Tavares S; Department of Pathology, University Medical Center Utrecht, 3584CX Utrecht, the Netherlands.
  • Liv N; Section Cell Biology, Center for Molecular Medicine, University Medical Center Utrecht, 3584CX Utrecht, the Netherlands.
  • Pasolli M; Cell Biology, Neurobiology, and Biophysics, Department of Biology, Faculty of Science, Utrecht University, 3584CH Utrecht, the Netherlands.
  • Opdam M; Department of Molecular Pathology, Netherlands Cancer Institute, 1066CX Amsterdam, the Netherlands.
  • Rätze MAK; Department of Pathology, University Medical Center Utrecht, 3584CX Utrecht, the Netherlands.
  • Saornil M; Department of Pathology, University Medical Center Utrecht, 3584CX Utrecht, the Netherlands.
  • Sluimer LM; Department of Pathology, University Medical Center Utrecht, 3584CX Utrecht, the Netherlands.
  • Hengeveld RCC; Oncode Institute, Department of Molecular Cancer Research, University Medical Center Utrecht, 3584CX Utrecht, the Netherlands.
  • van Es R; Oncode Institute, Department of Molecular Cancer Research, University Medical Center Utrecht, 3584CX Utrecht, the Netherlands.
  • van Werkhoven E; Department of Molecular Pathology, Netherlands Cancer Institute, 1066CX Amsterdam, the Netherlands.
  • Vos H; Oncode Institute, Department of Molecular Cancer Research, University Medical Center Utrecht, 3584CX Utrecht, the Netherlands.
  • Rehmann H; Flensburg University of Applied Sciences, 24943 Flensburg, Germany.
  • Burgering BMT; Oncode Institute, Department of Molecular Cancer Research, University Medical Center Utrecht, 3584CX Utrecht, the Netherlands.
  • Oosterkamp HM; Department of Medical Oncology, Haaglanden Medisch Centrum, 2501 CK The Hague, the Netherlands.
  • Lens SMA; Oncode Institute, Department of Molecular Cancer Research, University Medical Center Utrecht, 3584CX Utrecht, the Netherlands.
  • Klumperman J; Section Cell Biology, Center for Molecular Medicine, University Medical Center Utrecht, 3584CX Utrecht, the Netherlands.
  • Linn SC; Department of Pathology, University Medical Center Utrecht, 3584CX Utrecht, the Netherlands; Department of Molecular Pathology, Netherlands Cancer Institute, 1066CX Amsterdam, the Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, 1066CX Amsterdam, the Netherlands.
  • Derksen PWB; Department of Pathology, University Medical Center Utrecht, 3584CX Utrecht, the Netherlands. Electronic address: p.w.b.derksen@umcutrecht.nl.
Cell Rep ; 39(1): 110584, 2022 04 05.
Article in En | MEDLINE | ID: mdl-35385742
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Triple Negative Breast Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Cell Rep Year: 2022 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Triple Negative Breast Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Cell Rep Year: 2022 Document type: Article Affiliation country: